NCT07791628

Brief Summary

Sleep disturbance is one of the most common and most persistent symptoms in patients admitted for cancer care, and the options available during a short hospital stay are limited. The human body is electrically conductive, so an alternating potential - known as body voltage - is induced on the skin by mains wiring and appliances near the bed. Body voltage can be lowered by connecting the body to earth, and higher body voltage has been reported to be associated with lower vagal (parasympathetic) tone. This randomised, sham-controlled trial tested whether nightly electrical grounding improves sleep quality in hospitalised patients with cancer who also have clinically significant insomnia. Participants wore a hydrogel patch on the forehead connected by a cord either to a true earth connection or to an externally identical cord that did not complete a conductive circuit. Grounding was applied on two consecutive nights in the oncology ward and then nightly at home until the outpatient follow-up visit. Body voltage was measured before and during grounding in both settings, so that the trial could verify objectively whether the intervention achieved its intended physical effect. Sleep quality, mood, somatic symptoms and daytime sleepiness were assessed by validated self-report questionnaires.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
25

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 25, 2023

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2024

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

August 24, 2026

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 28, 2026

Completed
Last Updated

August 28, 2026

Status Verified

August 1, 2026

Enrollment Period

7 months

First QC Date

August 24, 2026

Last Update Submit

August 27, 2026

Conditions

Keywords

electrical groundingearthingbody voltageelectromagnetic fieldbedroom environmentinsomniaPittsburgh Sleep Quality Indexoncology inpatientssham-controlled

Outcome Measures

Primary Outcomes (4)

  • Change in PSQI scores

    The PSQI is a 19-item self-report instrument assessing sleep quality over the preceding month. It yields a global score ranging from 0 to 21, obtained by summing seven component scores each rated 0 to 3. Higher scores indicate poorer sleep quality.

    first: Baseline (before the first study night) second: the outpatient follow-up visit, scheduled 7 to 14 days after hospital discharge

  • Change in Pittsburgh Sleep Quality Index (PSQI) component scores

    Seven components of the PSQI, each scored 0 to 3: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Higher scores indicate poorer sleep.

    Baseline (before the first study night) and the outpatient follow-up visit, scheduled 7 to 14 days after hospital discharge

  • Leeds Sleep Evaluation Questionnaire (SEQ) domain scores

    Self-rated change in sleep attributable to treatment, across four domains: getting to sleep, quality of sleep, awake following sleep, and behaviour following wakening. Each domain is scored on visual analogue scales; higher scores indicate better sleep. The instrument asks the respondent to compare current sleep with the period before treatment and therefore has no pre-treatment value.

    Morning after the first in-hospital study night, morning after the second in-hospital study night, and the outpatient follow-up visit 7 to 14 days after discharge

  • Body voltage at the fingertip

    Alternating-current potential in volts, measured with a digital multimeter at the fingertip while the participant lies in bed, recorded immediately before and during grounding. Lower values indicate less induced electrical potential on the body.

    Once at first enrollment (on the day before two in-hospital study nights), and once in the participant's own bedroom within 2 days of hospital discharge

Secondary Outcomes (3)

  • Change in Hospital Anxiety and Depression Scale (HADS) score

    Baseline and the outpatient follow-up visit 7 to 14 days after discharge

  • Change in Depression and Somatic Symptoms Scale (DSSS) score

    Baseline and the outpatient follow-up visit 7 to 14 days after discharge

  • Change in Karolinska Sleepiness Scale (KSS) daily total

    Baseline, the mornings following each of the two in-hospital study nights, and the outpatient follow-up visit 7 to 14 days after discharge

Other Outcomes (1)

  • Bedroom Electromagnetic Environment Questionnaire (BrEQ)

    Once, during the remote video assessment within 2 days of hospital discharge

Study Arms (2)

grounding

EXPERIMENTAL

A hydrogel patch applied to the forehead is connected by a conductive cord to a true earth connection (the earth terminal of the bedside mains outlet in hospital, or a metal window frame at home). Applied from 21:00 to 06:00 on two consecutive nights in the ward and then nightly at home for at least six hours until the outpatient follow-up visit.

Device: Earthing patch; grounding electrode

sham grounding

SHAM COMPARATOR

A hydrogel conductive patch applied to the participants' forehead skin is connected by an electrically 'non-conductive' cord to a true earth connection (the earth terminal of the bedside mains outlet in hospital, or a metal window frame at home). Applied from 21:00 to 06:00 on two consecutive nights in the hospital ward and then nightly at home for at least six hours for 7 days before the outpatient follow-up visit.

Device: Sham (No Treatment)

Interventions

A Medical-grade hydrogel conductive patch ( 4 x 5 cm ) applied to the participants' forehead skin is connected by an electrically conductive cord to a true earth connection (the earth terminal of the bedside mains outlet in hospital, or a metal window frame at home). Applied from 21:00 to 06:00 on two consecutive nights in the hospital ward and then nightly at home for at least six hours for 7 days before the outpatient follow-up visit. Assigned Intervention Device: true Electrical grounding patch

grounding

Medical-grade hydrogel patch of approximately 4 x 5 cm applied to the forehead and connected by a sham-grounding cord (not conductively connected ) to an earth connection point. Assigned Intervention Device: sham-grounding cord

sham grounding

Eligibility Criteria

Age20 Years - 79 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inpatients of the oncology ward aged 20 to 79 years
  • Subjective complaint of insomnia, with a Pittsburgh Sleep Quality Index global score of 10 or greater at baseline
  • Histologically or clinically confirmed cancer of any stage from 0 to IV
  • Intact forehead skin permitting application of a grounding patch
  • Scheduled hospital admission of more than three days
  • Able and willing to give written informed consent

You may not qualify if:

  • Baseline Pittsburgh Sleep Quality Index global score of 9 or less
  • Known or suspected pregnancy
  • History of alcohol dependence with less than two months of abstinence
  • Recent use of an indoor grounding product during sleep for more than one month
  • Habitually walking barefoot outdoors for more than one hour a day for more than one month
  • Unable or unwilling to complete the study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

New Taipei City Municipal TuCheng Hospital

New Taipei City, TuCheng District, 236, Taiwan

Location

Related Links

MeSH Terms

Conditions

NeoplasmsSleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Chun-Hsien Tu, MD

    New Taipei City Municipal TuCheng Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 24, 2026

First Posted

August 28, 2026

Study Start

October 25, 2023

Primary Completion

June 5, 2024

Study Completion

June 5, 2024

Last Updated

August 28, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations